{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:49Z","timestamp":1790774689578,"version":"4.1.0"},"reference-count":26,"publisher":"Bioscientifica","issue":"5","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The objective of this study is to investigate the association between serum meteorin-like protein (Metrnl) and metabolic dysfunction-associated steatotic liver disease (MASLD) in type 2 diabetes mellitus (T2DM) and evaluate its incremental discriminatory value beyond the Hepatic Steatosis Index (HSI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled 198 T2DM patients (110 T2DM-only; 88 T2DM + MASLD). Metrnl levels were measured via ELISA. Multivariable and ordinal logistic regressions assessed the independent association between the Metrnl and MASLD presence and ultrasonographic severity, adjusting for clinical confounders. Discriminatory performance was evaluated using ROC analyses and likelihood-ratio tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum Metrnl was significantly lower in the T2DM + MASLD group versus T2DM-only (0.65 (0.46, 0.82) vs 0.75 (0.62, 0.88) ng\/mL, P = 0.007). After full adjustment for adiposity, lipids, liver enzymes, and insulin resistance, lower Metrnl remained independently associated with higher MASLD risk (OR = 0.238, 95% CI: 0.061\u20130.931, P = 0.039) and greater steatosis severity (P &amp;lt; 0.001). Adding Metrnl to HSI significantly improved the diagnostic model fit (AUC increased from 0.727 to 0.747, P = 0.011).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Decreased serum Metrnl is independently associated with the MASLD presence and severity in T2DM, irrespective of obesity and insulin resistance. Metrnl serves as a distinct metabolic correlate, offering modest incremental value in multiparameter risk assessment models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-25-0885","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:54:38Z","timestamp":1778849678000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Association between serum meteorin-like protein and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: a cross-sectional study"],"prefix":"10.1530","volume":"15","author":[{"given":"Yanqian","family":"Zhuang","sequence":"first","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongkun","family":"Xu","sequence":"additional","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Chen","sequence":"additional","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2517-6402","authenticated-orcid":true,"given":"Wen","family":"Guo","sequence":"additional","affiliation":[{"name":"Fuzong Clinical Medical College of Fujian Medical University, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"2026091106563612900_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"2026091106563612900_bib2","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026091106563612900_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"2026091106563612900_bib4","article-title":"Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling","volume":"44","author":"Chen","year":"2025","journal-title":"Cell Rep"},{"key":"2026091106563612900_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.diabres.2019.02.026","article-title":"Association of low serum meteorin like (Metrnl) concentrations with worsening of glucose tolerance, impaired endothelial function and atherosclerosis","volume":"150","author":"El-Ashmawy","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091106563612900_bib6","first-page":"1","article-title":"Metrnl attenuates lipid-induced inflammation and insulin resistance via AMPK or PPAR\u03b4-dependent pathways in skeletal muscle of mice","volume":"50","author":"Jung","year":"2018","journal-title":"Exp Mol Med"},{"key":"2026091106563612900_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115246","article-title":"Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation","volume":"44","author":"Song","year":"2025","journal-title":"Cell Rep"},{"key":"2026091106563612900_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.938341","article-title":"Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile","volume":"13","author":"Ding","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026091106563612900_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.abn3027","article-title":"Meteorin-like promotes heart repair through endothelial KIT receptor tyrosine kinase","volume":"376","author":"Reboll","year":"2022","journal-title":"Science"},{"key":"2026091106563612900_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108068","article-title":"Inverse relationship between serum Metrnl levels and visceral fat obesity (VFO) in patients with type 2 diabetes","volume":"161","author":"Du","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091106563612900_bib11","article-title":"Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-\u03b21\/Smads signaling pathway: a potential therapeutic target","volume":"19","author":"Lin","year":"2024","journal-title":"PLoS One"},{"key":"2026091106563612900_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.diabres.2017.11.031","article-title":"Implications of circulating meteorin-like (Metrnl) level in human subjects with type 2 diabetes","volume":"136","author":"Chung","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091106563612900_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41419-025-07734-6","article-title":"Cellular crosstalk mediated by meteorin-like regulating hepatic stellate cell activation during hepatic fibrosis","volume":"16","author":"Zhou","year":"2025","journal-title":"Cell Death Dis"},{"key":"2026091106563612900_bib14","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.3390\/jcm10194338","article-title":"Meteorin-like protein (Metrnl) in obesity, during weight loss and in adipocyte differentiation","volume":"10","author":"Schmid","year":"2021","journal-title":"J Clin Med"},{"key":"2026091106563612900_bib15","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2026091106563612900_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2024","journal-title":"J Hepatol"},{"key":"2026091106563612900_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"2026091106563612900_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","article-title":"Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease","volume":"76","author":"Govaere","year":"2022","journal-title":"J Hepatol"},{"key":"2026091106563612900_bib19","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.12659\/MSM.915331","article-title":"Serum levels of meteorin-like (Metrnl) are increased in patients with newly diagnosed type 2 diabetes mellitus and are associated with insulin resistance","volume":"25","author":"Wang","year":"2019","journal-title":"Med Sci Monit"},{"key":"2026091106563612900_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.diabres.2017.10.005","article-title":"Serum meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes","volume":"135","author":"Lee","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"2026091106563612900_bib21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"2026091106563612900_bib22","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.4049\/jimmunol.1800435","article-title":"Meteorin-like\/meteorin-\u03b2 is a novel immunoregulatory cytokine associated with inflammation","volume":"201","author":"Ushach","year":"2018","journal-title":"J Immunol"},{"key":"2026091106563612900_bib23","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med"},{"key":"2026091106563612900_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"2026091106563612900_bib25","article-title":"Meteorin-like ameliorates \u03b2 cell function by inhibiting \u03b2 cell apoptosis of and promoting \u03b2 cell proliferation via activating the WNT\/\u03b2-Catenin pathway","volume":"12","author":"Hu","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026091106563612900_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/aps.2016.9","article-title":"Metrnl: a secreted protein with new emerging functions","volume":"37","author":"Zheng","year":"2016","journal-title":"Acta Pharmacol Sin"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/15\/5\/EC-25-0885.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/15\/5\/EC-25-0885.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0885\/504753\/ec-25-0885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0885\/504753\/ec-25-0885.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:56:46Z","timestamp":1789124206000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/5\/e250885\/75375\/Association-between-serum-meteorin-like-protein"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0885","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"e250885"}}